S. 2531 · 119th Congress
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Not yet voted on. This bill is still a proposal: it hasn't reached a floor vote, and its text can change in committee or on the floor before any vote.
D
AlsobrooksSponsor4 cosponsors · 2 D, 2 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
What it does: CRS summary · Introduced in Senate · Jul 30, 2025
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
This bill authorizes grants to support early detection of and intervention for uterine fibroids. Uterine fibroids are tumors in the wall of the uterus that are usually benign but can cause painful and heavy menstrual bleeding and other symptoms.
The bill requires the Department of Health and Human Services (HHS) to (1) conduct or support research on increasing early detection of and medical intervention for uterine fibroids, and (2) formulate strategies to increase early detection based on such research.
Also, the bill authorizes HHS to provide grants to states to increase early detection of and intervention for uterine fibroids (e.g., screenings) and to carry out public awareness campaigns. Additionally, the bill authorizes HHS to provide grants to states for research relating to (1) disparities in pain management in uterine fibroid surgical treatment; or (2) uterine health conditions, as determined appropriate by HHS.
HHS must report to Congress every two years on the activities funded by grants under the bill, including findings from the research conducted by states.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Latest action (Mar 19, 2026): Committee on Health, Education, Labor, and Pensions. Hearings held.
Policy area: Health · Origin: Senate · Introduced: Jul 30, 2025
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.